Skip to content

Search and verification test of genome and bio-markers for the purpose of constructing an individualized treatment algorithm for dementia and mild cognitive impairment

Search and verification test of genome and bio-markers for the purpose of constructing an individualized treatment algorithm for dementia and mild cognitive impairment - Precision medicine research in dementia and mild cognitive impairment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000039487
Enrollment
1120
Registered
2020-03-01
Start date
2020-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major or Mild Neurocognitive Disorder Due to Alzheimer&#39

Interventions

None listed

Sponsors

Kansai Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Person diagnosed with dementia or mild cognitive impairment with DSM-IV-TR or DSM-5 2. Person diagnosed with cognitive impairment due to delirium with DSM-IV-TR or DSM-5 3. Person whose age is 20 years old or older 4. Person who gained consent by free will with document

Exclusion criteria

Exclusion criteria: 1. Person who cannot obtain consent from the person or his/her behalf 2. Person who is deemed ineligible by the principal investigator or sharing researcher

Design outcomes

Primary

MeasureTime frame
Cognitive Function Evaluation : Mini-Mental State Examination (MMSE)

Secondary

MeasureTime frame
NPI-Brief Questionnaire Form (NPI-Q)

Countries

Japan

Contacts

Public ContactYuji Murase

Kansai Medical University Department of Neuropsychiatry

murasey@takii.kmu.ac.jp06-6992-1001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026